- Gene mutations in circulating tumour dna as a diagnostic and prognostic marker in head and neck cancer-a systematic review2021 | First Faculty of Medicine
- Combination of Circulating Tumour DNA and 18F-FDG PET/CT for Precision Monitoring of Therapy Response in Patients With Advanced Non-small Cell Lung Cancer: A Prospective Study2022 | Faculty of Medicine in Pilsen, Faculty of Science, Central Library of Charles University
- Significance and benefit of testing for circulating tumour DNA in diagnosing and treating non-small cell lung cancer2021 | Faculty of Medicine in Pilsen
- Chemotherapy effectivity prediction of dynamics PET/dual scans and ctDNA tumour levels in advanced pulmonary adenocarcinomasPublication without faculty affiliation
- Circulating Cell-Free DNA Extraction from Liquid Biopsy for Cancer Research2022 | First Faculty of Medicine
- Treatment of non-small cell lung cancer with a driver mutation2022 | Faculty of Medicine in Pilsen
- Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA2020 | First Faculty of Medicine
- The evolving landscape of biomarker testing for non-small cell lung cancer in Europe2021 | Faculty of Medicine in Hradec Králové